216 related articles for article (PubMed ID: 34278478)
21. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300.
Shen P; Feng X; Zhang X; Huang X; Liu S; Lu X; Li J; You J; Lu J; Li Z; Ye J; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):31-40. PubMed ID: 27094368
[TBL] [Abstract][Full Text] [Related]
22. ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation.
Liu X; Lin L; Li Q; Ni Y; Zhang C; Qin S; Wei J
BMC Mol Cell Biol; 2019 Jun; 20(1):14. PubMed ID: 31200637
[TBL] [Abstract][Full Text] [Related]
23. Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2.
Sun Y; Chen C; Xue R; Wang Y; Dong B; Li J; Chen C; Jiang J; Fan W; Liang Z; Huang H; Fang R; Dai G; Yan Y; Yang T; Li X; Huang ZP; Dong Y; Liu C
Theranostics; 2019; 9(24):7268-7281. PubMed ID: 31695767
[No Abstract] [Full Text] [Related]
24. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
25. Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF.
Pan B; Liu C; Su J; Xia C
Cell Commun Signal; 2024 Jun; 22(1):306. PubMed ID: 38831454
[TBL] [Abstract][Full Text] [Related]
26. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
[TBL] [Abstract][Full Text] [Related]
27. Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice.
Sunagawa Y; Tsukabe R; Irokawa Y; Funamoto M; Suzuki Y; Yamada M; Shimizu S; Katanasaka Y; Hamabe-Horiike T; Kawase Y; Naruta R; Shimizu K; Mori K; Hosomi R; Komiyama M; Hasegawa K; Morimoto T
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397020
[TBL] [Abstract][Full Text] [Related]
28. Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo.
Si L; Xu J; Yi C; Xu X; Wang F; Gu W; Zhang Y; Wang X
Int J Mol Med; 2014 Aug; 34(2):499-506. PubMed ID: 24827470
[TBL] [Abstract][Full Text] [Related]
29. The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice.
Qiao W; Zhang W; Gai Y; Zhao L; Fan J
Biochem Biophys Res Commun; 2014 Jun; 448(4):379-84. PubMed ID: 24802406
[TBL] [Abstract][Full Text] [Related]
30. Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy.
Ng DC; Ng IH; Yeap YY; Badrian B; Tsoutsman T; McMullen JR; Semsarian C; Bogoyevitch MA
J Biol Chem; 2011 Jan; 286(2):1576-87. PubMed ID: 21056972
[TBL] [Abstract][Full Text] [Related]
31. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.
Wei JQ; Shehadeh LA; Mitrani JM; Pessanha M; Slepak TI; Webster KA; Bishopric NH
Circulation; 2008 Aug; 118(9):934-46. PubMed ID: 18697823
[TBL] [Abstract][Full Text] [Related]
32. PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.
Li J; Gao H; Huang J; Wang P; Huang Y; Luo W; Zhang X; Shen P; You J; Cai S; Li Z; Liu P
J Pharmacol Sci; 2016 Sep; 132(1):15-23. PubMed ID: 27094369
[TBL] [Abstract][Full Text] [Related]
33. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
34. TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4.
Song R; Lei H; Feng L; Cheng W; Li Y; Yao LL; Liu J
J Biol Chem; 2021 Oct; 297(4):101189. PubMed ID: 34517007
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.
Wong K; Sharma A; Awasthi S; Matlock EF; Rogers L; Van Lint C; Skiest DJ; Burns DK; Harrod R
J Biol Chem; 2005 Mar; 280(10):9390-9. PubMed ID: 15611041
[TBL] [Abstract][Full Text] [Related]
36. Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac.
Tian P; Zhu Y; Zhang C; Guo X; Zhang P; Xue H
BMC Cancer; 2018 Dec; 18(1):1286. PubMed ID: 30577849
[TBL] [Abstract][Full Text] [Related]
37. The histone acetyltransferase activity of PCAF cooperates with the brahma/SWI2-related protein BRG-1 in the activation of the enhancer A of the MHC class I promoter.
Brockmann D; Lehmkühler O; Schmücker U; Esche H
Gene; 2001 Oct; 277(1-2):111-20. PubMed ID: 11602348
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
39. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
40. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
